Gupta, R;
Shipa, M;
Yeoh, S-A;
Buck, P;
Ehrenstein, MR;
(2021)
An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic.
Rheumatology
, 60
(2)
pp. 977-979.
10.1093/rheumatology/keaa653.
Preview |
Text
Ehrenstein_An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID.pdf - Accepted Version Download (275kB) | Preview |
Downloads since deposit
5,928Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
View Item |